A roadmap to increasing access to AQP4-Ig testing for NMOSD: expert recommendations.

Raquel Vassão-Araujo1,2, Samira Apóstolos3, Angela Marie Jansen4

  • 1Santa Casa de Belo Horizonte (CAPPEM), Departamento de Neurologia, Belo Horizonte MG, Brazil.

PubMed
Summary

Neuromyelitis optica spectrum disorder (NMOSD) diagnosis in Brazil is hindered by limited access to aquaporin 4 immunoglobulin G (AQP4-IgG) testing. Improving physician knowledge and healthcare access is crucial for better patient outcomes.